FLUOXETINE HYDROCHLORIDE (fluoxetine hcl) by PharmaIN is serotonin uptake inhibitors [moa]. First approved in 2024.
Drug data last refreshed 1w ago
Serotonin Uptake Inhibitors
Serotonin Reuptake Inhibitor
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition
Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed Condition
90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions
90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions
To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg
Worked on FLUOXETINE HYDROCHLORIDE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.